+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchiectasis Drugs Market by Drug Type (Anti-Inflammatory Agents, Antibiotics, Bronchodilators), Route Of Administration (Inhalation, Injection, Oral), Patient Demographics, Bronchiectasis Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Bronchiectasis Drugs Market by Drug Type (Anti-Inflammatory Agents, Antibiotics, Bronchodilators), Route Of Administration (Inhalation, Injection, Oral), Patient Demographics, Bronchiectasis Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Bronchiectasis Drugs Market by Drug Type (Anti-Inflammatory Agents, Antibiotics, Bronchodilators), Route Of Administration (Inhalation, Injection, Oral), Patient Demographics, Bronchiectasis Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011462
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bronchiectasis drugs market is evolving rapidly as rising clinical needs, shifting treatment paradigms, and collaborative innovation reshape the therapeutic landscape. Senior decision-makers now face a complex environment where emerging opportunities demand strategic agility and evidence-driven investment.

Market Snapshot: Bronchiectasis Drugs Market Growth and Outlook

The bronchiectasis drugs market grew from USD 1.52 billion in 2024 to USD 1.65 billion in 2025. It is expected to continue growing at a CAGR of 9.22%, reaching USD 2.58 billion by 2030. This upward trajectory is being fueled by greater disease recognition, innovation in pharmacological strategies, and the alignment of clinical protocol with patient-centric and value-based care demands.

Scope & Segmentation of the Bronchiectasis Drug Market

  • Drug Types: Anti-inflammatory agents (including corticosteroids and NSAIDs), antibiotics, bronchodilators (long-acting and short-acting), and mucolytics.
  • Route of Administration: Inhalation, injection (intravenous, subcutaneous), and oral therapies are represented to address both acute and chronic care needs.
  • Patient Demographics: Adult, geriatric, and pediatric segments—each with distinct treatment, safety, and efficacy profiles—shape commercial strategy and regulatory approaches.
  • Bronchiectasis Type: Cylindrical (tubular), varicose, and cystic phenotypes, with imaging and monitoring strategies adapted to each profile.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, and online pharmacies provide comprehensive market access and support varying dispensing models.
  • Regional Coverage: Americas (including U.S. states and Latin America), Europe, Middle East & Africa, and Asia-Pacific. Key territories span the U.S., Canada, Germany, Japan, China, India, and emerging economies.
  • Companies Profiled: Notable pharmaceutical innovators include AdvaCare Pharma, AstraZeneca PLC, Boehringer Ingelheim, Cipla Limited, GlaxoSmithKline PLC, Insmed Incorporated, and Sanofi S.A.

Bronchiectasis Drugs Market: Key Takeaways

  • The bronchiectasis drugs market is characterized by significant unmet needs, driving the shift from symptom relief to therapies that target disease pathobiology and improve patient quality of life.
  • Biomarker-guided approaches, personalized immunomodulation, and digital integration are fueling a transition from broad regimens to stratified patient care, enabling earlier intervention and optimizing therapeutic response.
  • Collaborative models involving academic research, biopharma, and commercial payers are breaking down traditional barriers and accelerating the translation of scientific discovery into market-ready innovation.
  • Enhanced regulatory flexibility—such as adaptive trial designs and real-world patient stratification—streamlines development, reduces costs, and increases the relevance of clinical endpoints across patient populations.
  • Distribution models are diversifying with the rise of online and specialty pharmacy channels, which, together with hospital settings, enable tailored access strategies and support patient adherence initiatives.

Tariff Impact: Navigating 2025 U.S. Tariff Revisions

With anticipated U.S. tariff adjustments on raw materials and APIs in 2025, manufacturers are reassessing sourcing, inventory, and regional supply chain strategies. The resulting pricing pressures could impact not only domestic cost structures but also influence payer negotiations and reimbursement dialogues globally. Geographic diversification of production, strategic supplier agreements, and digital traceability solutions are emerging as proactive measures to ensure market resilience and operational continuity.

Methodology & Data Sources for Bronchiectasis Market Insights

Analysis is grounded in a balanced combination of secondary research from peer-reviewed journals, trial registries, and regulatory filings, as well as primary interviews with clinical leaders and industry executives. Quantitative validation drew on scientific databases and regulatory announcements, while qualitative findings were synthesized through cross-stakeholder workshops and expert panels to ensure comprehensive and robust assessment.

Why This Report Matters for Decision-Makers

  • Enables informed, forward-looking investment decisions by mapping evolving therapeutic innovations, changing payer expectations, and patient-centric trends.
  • Supports effective risk management and competitive strategy by assessing regulatory, supply chain, and reimbursement challenges across multiple regions.

Conclusion

Bronchiectasis drug development is entering a period of accelerated innovation, where cross-sector collaboration, adaptive technologies, and patient engagement drive meaningful progress. Stakeholders prepared to align strategy with evolving clinical and market dynamics will be best positioned for sustainable success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Efficacy and safety outcomes of inhaled liposomal antibiotics in bronchiectasis management
5.2. Utilization of CFTR modulators repurposed for non-cystic fibrosis bronchiectasis therapy
5.3. Development of monoclonal antibody treatments targeting neutrophilic inflammation pathways in bronchiectasis
5.4. Emerging small molecule biofilm dispersal agents to enhance antibiotic activity in bronchiectasis patients
5.5. Integration of biomarker-driven patient stratification models for personalized bronchiectasis drug therapy
5.6. Impact of real-world evidence studies on long-term outcomes and payer reimbursement in bronchiectasis
5.7. Regulatory incentives and orphan drug designations accelerating novel bronchiectasis treatment approvals
5.8. Challenges of antimicrobial resistance and stewardship in designing next-generation bronchiectasis antibiotics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bronchiectasis Drugs Market, by Drug Type
8.1. Introduction
8.2. Anti-Inflammatory Agents
8.2.1. Corticosteroids
8.2.2. NSAIDs
8.3. Antibiotics
8.4. Bronchodilators
8.4.1. Long-Acting Bronchodilators
8.4.2. Short-Acting Bronchodilators
8.5. Mucolytics
9. Bronchiectasis Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Injection
9.3.1. Intravenous
9.3.2. Subcutaneous
9.4. Oral
10. Bronchiectasis Drugs Market, by Patient Demographics
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Bronchiectasis Drugs Market, by Bronchiectasis Type
11.1. Introduction
11.2. Cylindrical (Tubular)
11.3. Varicose (Cystic)
12. Bronchiectasis Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Bronchiectasis Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bronchiectasis Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bronchiectasis Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AdvaCare Pharma
16.3.2. Armata Pharmaceuticals
16.3.3. AstraZeneca PLC
16.3.4. Bayer AG
16.3.5. Boehringer Ingelheim International GmbH
16.3.6. Cipla Limited
16.3.7. F. Hoffmann-La Roche AG
16.3.8. GlaxoSmithKline PLC
16.3.9. Glenmark Pharmaceuticals Limited
16.3.10. Insmed Incorporated
16.3.11. Lupin Limited
16.3.12. Merck & Co., Inc.
16.3.13. Mylan Inc. by Viatris Inc.
16.3.14. Nephron Pharmaceuticals Corporation
16.3.15. Novartis AG
16.3.16. Perrigo Company PLC
16.3.17. Pfizer Inc.
16.3.18. Renovion, Inc.
16.3.19. Sanofi S.A.
16.3.20. Steris Healthcare Pvt. Ltd.
16.3.21. Sun Pharmaceutical Industries Limited
16.3.22. Teva Pharmaceutical Industries Ltd.
16.3.23. Verona Pharma PLC
16.3.24. ZAMBON COMPANY S.P.A.
16.3.25. Zydus Group
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRONCHIECTASIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRONCHIECTASIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRONCHIECTASIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRONCHIECTASIS DRUGS MARKET: RESEARCHAI
FIGURE 26. BRONCHIECTASIS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRONCHIECTASIS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. BRONCHIECTASIS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRONCHIECTASIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY LONG-ACTING BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY LONG-ACTING BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY SHORT-ACTING BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY SHORT-ACTING BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY CYLINDRICAL (TUBULAR), BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY CYLINDRICAL (TUBULAR), BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY VARICOSE (CYSTIC), BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY VARICOSE (CYSTIC), BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRONCHIECTASIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BRONCHIECTASIS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 106. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 107. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 108. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 109. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 112. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 113. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 114. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 115. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 252. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 253. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 254. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 255. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 258. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 259. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 260. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 261. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 262. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 263. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHIECTASIS TYPE, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA BRONCHIECTASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA BRONCHIECTASIS DRUGS MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AF

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bronchiectasis Drugs market report include:
  • AdvaCare Pharma
  • Armata Pharmaceuticals
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Insmed Incorporated
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan Inc. by Viatris Inc.
  • Nephron Pharmaceuticals Corporation
  • Novartis AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Renovion, Inc.
  • Sanofi S.A.
  • Steris Healthcare Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Verona Pharma PLC
  • ZAMBON COMPANY S.P.A.
  • Zydus Group

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.65 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.58 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Bronchiectasis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Bronchiectasis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 203 Pages
  • Global
From
Bronchiectasis Drugs - Global Strategic Business Report - Product Image

Bronchiectasis Drugs - Global Strategic Business Report

  • Report
  • 207 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 170 Pages +
  • Global
From
Non-Cystic Fibrosis Bronchiectasis Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035 - Product Image

Non-Cystic Fibrosis Bronchiectasis Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035

  • Report
  • 100 Pages
  • Global
From
Bronchiectasis Epidemiology Forecast 2025-2034 - Product Image

Bronchiectasis Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From

About the Market

Bronchiectasis is a chronic lung disease that causes irreversible damage to the airways. It is characterized by abnormal and irreversible widening of the bronchi, leading to recurrent infections and difficulty breathing. Treatment for bronchiectasis includes antibiotics, bronchodilators, and mucolytics. Inhaled corticosteroids may also be used to reduce inflammation. The bronchiectasis drug market is a subset of the larger respiratory drug market. It is composed of drugs used to treat bronchiectasis, including antibiotics, bronchodilators, mucolytics, and inhaled corticosteroids. These drugs are used to reduce inflammation, reduce mucus production, and improve airway clearance. Some companies in the bronchiectasis drug market include GlaxoSmithKline, AstraZeneca, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.